A nondestructive technique to determine the rate of oxygen permeation into solid dosage forms

Pharmaceutical Development and Technology

Volumn 11, Issue 1, 2006, Pages 141-147

  Felton, L A ^a   Timmins, G S ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Capsule; Coating; Electroparamagnetic resonance spectroscopy; EPR; Gelatin; Hydroxypropyl methylcellulose; Oxygen permeation; Tablet

Indexed keywords

AEROSIL; AVICEL PH 302; CELLULOSE; GELATIN; LITHIUM DERIVATIVE; LITHIUM PHTHALOCYANINE; MAGNESIUM STEARATE; MICROCRYSTALLINE CELLULOSE; PHTHALOCYANINE DERIVATIVE; POLYMER; PROSOLV 90; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ARTICLE; CALIBRATION; CONCENTRATION (PARAMETERS); CRYSTAL; DRUG CAPSULE; DRUG DOSAGE FORM; ELECTRON SPIN RESONANCE; FILM; FORCE; OXYGEN TENSION; PERMEABILITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TABLET; TABLET COMPRESSION; TECHNIQUE;

CAPSULES; CELLULOSE; DRUG STABILITY; ELECTRON SPIN RESONANCE SPECTROSCOPY; EXCIPIENTS; GELS; KINETICS; MICROSCOPY, ELECTRON, SCANNING; OXIDATION-REDUCTION; OXYGEN; PERMEABILITY; TABLETS; TABLETS, ENTERIC-COATED;

EID: 33644983335     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.1080/10837450600561208     Document Type: Article

References (20)

1. Khossravi, M.; Borchardt, R.T. Chemical pathways of peptide degradation: IX. Metal-catalyzed oxidation of histidine in model peptides. Pharm. Res. 1998, 15 (7), 1096-1102.
2. Townsend, M.W.; Byron, P.R.; DeLuca, P.P. The effects of formulation additives on the degradation of freeze-dried ribonuclease A. Pharm. Res. 1990, 17 (10), 1086-1091.
3. Farmer, S., et al. Forced degradation of ibuprofen in bulk drug and tablets. Pharm. Tech. 2002, 26 (5), 28-42.
4. Kumar, V.; Sunder, N.; Potdar, A. Critical factors in developing pharmaceutical formulations - An overview, part II. Pharm. Tech. 1992 (April), 86-92.
5. Hartauer, K.J., et al. Influence of peroxide impurities in povidone and crospovidone on the stability of raloxifene hydrochloride in tablets: Identification and control of an oxidative degradation product. Pharm. Dev. Technol. 2000, 5(3), 303-310.
6. Monkhouse, D.C. Stability aspects of preformulation and formulation of solid pharmaceuticals. Drug Dev. Ind. Pharm. 1984, 10 (8&9), 1373-1412.
7. Templeton, A.C., et al. Rapid headspace oxygen analysis for pharmaceutical packaging applications. Pharm. Tech. 2002, 26 (7), 44-61.
8. Waterman, K.C., et al. Stabilization of pharmaceuticals to oxidative degradation. Pharm. Dev. Technol. 2002, 7 (1), 1-32.
9. List, P.H.; Kassis, G. On the permeability of various tablet coatings to water vapour and oxygen. Acta Pharm. Technol. 1982, 28, 21-33.
10. Waterman, K.C.; Roy, M.C. Use of oxygen scavengers to stabilize solid pharmaceutical dosage forms: A case study. Pharm. Dev. Technol. 2002, 7 (2), 227-234.
11. Mader, K., et al. Noninvasive in vivo monitoring of drug release and polymer erosion from biodegradable polymers by EPR spectroscopy and NMR imaging. J. Pharm. Sci. 1997, 86 (1), 126-134.
12. Mader, K., et al. Monitoring microviscosity and microacidity of the albumin microenvironment inside degrading microparticles from PLG or ABA-triblock polymers containing hydrophobic PLG A blocks and hydrophilic poly(ethyleneoxide) B blocks. Pharm. Res. 1998, 15 (6), 787-793.
13. Liu, K.J., et al. Lithium phthalocyanine: A probe for electron paramagnetic resonance oximetry in viable biological systems. Proc. Natl. Acad. Sci. 1993, 90, 5438-5442.
14. Timmins, G.S.; Bechara, E.J.H.; Swartz, H.M. Direct determination of the kinetics of oxygen diffusion to the photocytes of a bioluminescent elaterid larva, measurement of gas-and aqueous-phase diffusional barriers and modelling of oxygen supply. J. Exp. Biol. 2000, 203 (16), 2479-2484.
15. Young, C.R.; Koleng, J.J.; McGinity, J.W. Production of spherical pellets by a hot-melt extrusion and spheronization process. Int. J. Pharm. 2002, 242, 87-92.
16. Crowley, M.M., et al. Physicochemical properties and mechanism of drug release from ethyl cellulose matrix tablets prepared by direct compression and hot-melt extrusion. Int. J. Pharm. 2004, 269, 509-522.
17. Felton, L.A.; Perry, W.L. A novel technique to quantify film-tablet interfacial thickness. Pharm. Dev. Technol. 2002, 7 (1), 1-5.
18. Felton, L.A.; McGinity, J.W. Influence of tablet hardness and hydrophobicity on the adhesive properties of an acrylic resin copolymer. Pharm. Dev. Technol. 1996, 1 (4), 381-389.
19. Gulian, F.J., et al., Oxidative protection of ibuprofen using Opadry fx special effects film coating system. AAPS PharmSci. 2004, 6 (4), W5078.
20. Hom, F.S.; Veresh, S.A.; Ebert, W.R. Soft gelatin capsules II: Oxygen permeability study of capsule shells. J. Pharm. Sci. 1975, 64(5), 851-857.